x

PaxVax: Acquired by Emergent BioSolutions

PaxVax: Transforming the World with Novel Specialty Vaccines

PaxVax: Infectious Diseases Know No Borders—Neither Do We

PaxVax: Where Disease Protection is Lacking, PaxVax Sees Opportunity

About PaxVax

PaxVax is an independent vaccine company with a robust pipeline and commercialized products, focused on specialty vaccines that protect against overlooked infectious diseases.

PaxVax Vaccines

We address overlooked public health challenges such as cholera, typhoid and more.

Careers at PaxVax

Join a pioneering global healthcare company with a sense of purpose.

Latest Media

PRESS RELEASE

Emergent BioSolutions Completes Acquisition of Specialty Vaccines Company Paxvax

GAITHERSBURG, Md., October 4, 2018 – Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of...
NEWS

Vaccine Maker PaxVax Tackles The Unmet Need Posed By Chikungunya Virus

PaxVax CEO Nima Farzan discusses PaxVax’s commitment to vaccine development to prevent against disease caused by the chikungunya virus and...
23 Oct

Emergent BioSolutions has acquired PaxVax Inc. For continued news and updates, we encourage you to follow @emergentbiosolu.

About PaxVax
Who We Are

About PaxVax

PaxVax is an independent vaccine company with a robust pipeline that brings to market specialty vaccines that protect against existing and emerging infectious diseases.

Discover More
PaxVax our vaccines
What We Do

Our Vaccines

We provide innovative specialty vaccines for global public health challenges like cholera and typhoid.

View Our Vaccines
PaxVax vaccines pipeline
Pipeline

PaxVax strives to develop novel vaccines for infectious diseases against which there are either no available vaccines or for which few other companies are pursuing.

View Our Pipeline